FindTrial
Sign In

The study of urinary DcR2 in the progression and prognosis of IgA nephropathy

The study of urinary DcR2 in the progression and prognosis of IgA nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016254
Enrollment
Unknown
Registered
2018-05-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

Case series:Nil

Sponsors

Department of nephrology, Institute of Surgery Research, Daping hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Primary IgA nephropathy was diagnosed by renal biopsy from January 1, 2019 to December 31, 2019. All genders and the patients were 18-65 years old.

Exclusion criteria

Exclusion criteria: Secondary IgA nephropathy including purpura nephritis, lupus nephritis and hepatitis B. With primary and secondary kidney disease, acute kidney injury and tumor, severe hepatic or cardiac dysfunction. The biopsy tissue contains eight or less glomeruli.

Design outcomes

Primary

MeasureTime frame
urinary DcR2;serum creatinine;—

Countries

China

Contacts

Public ContactYani He

Department of nephrology, Institute of Surgery Research, Daping hospital, Army Medical University

heynmail@yahoo.com+86 023-68757871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026